Dose-finding methodology for peripheral nerve blocks

Regional Anesthesia and Pain Medicine

Volumn 39, Issue 6, 2014, Pages 550-555

  Saranteas, Theodosios ^a   Finlayson, Roderick ^a   Tran, De Q ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LOCAL ANESTHETIC AGENT;

ARTICLE; BAYES THEOREM; BIASED COIN DESIGN METHOD; DIXON MOOD METHOD; DOSE CALCULATION; DOSE RESPONSE; HUMAN; METHODOLOGY; NERVE BLOCK; OPTIMAL DRUG DOSE; PERIPHERAL NERVE BLOCK; PRIORITY JOURNAL; ANIMAL; DRUG EFFECTS; PERIPHERAL NERVE; PROCEDURES;

ANIMALS; BAYES THEOREM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; HUMANS; NERVE BLOCK; PERIPHERAL NERVES; RESEARCH DESIGN;

EID: 84930016652     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000157     Document Type: Article

References (51)

1. Tallarida RJ. Interactions between drugs and occupied receptors. Pharmacol Ther. 2007; 113: 197-209
2. Goutelle S, Maurin M, Rougier F, et al. The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol. 2008; 22: 633-648
3. Tzotzes V, Tzilalis V, Giannakakis S, et al. Effects of acute and chronic cadmium administration on the vascular reactivity of rat aorta. Biometals. 2007; 20: 83-91
4. Mourouzis C, Pantos C, Mourouzis I, et al. Mepivacaine alters vascular responsiveness to vasoconstrictors in aortic rings from normal and aortic-banded rats. Pharmacol Toxicol. 2003; 93: 269-274
5. Sharma MR, Stadler WM, Ratain MJ. Randomized phase II trials: a long-term investment with promising returns. J Natl Cancer Inst. 2011; 103: 1093-1100
6. Ding M, Rosner GL, Müller P. Bayesian optimal design for phase II screening trials. Biometrics. 2008; 64: 886-894
7. Paul M, Fisher DM. Are estimates of MAC reliable?. Anesthesiology. 2001; 95: 1362-1370
8. Columb MO, Lyons G. Determination of the minimum local analgesic concentrations of epidural bupivacaine and lidocaine in labor. Anesth Analg. 1995; 81: 833-837
9. Casati A, Baciarello M, Di Cianni S, et al. Effects of ultrasound guidance on the minimum effective anaesthetic volume required to block the femoral nerve. Br J Anaesth. 2007; 98: 823-827
10. McLeod GA, Dale J, Robinson D, et al. Determination of the EC50 of levobupivacaine for femoral and sciatic perineural infusion after total knee arthroplasty. Br J Anaesth. 2009; 102: 528-533
11. Gupta PK, Pace NL, Hopkins PM. Effect of body mass index on the ED50 volume of bupivacaine 0.5% for supraclavicular brachial plexus block. Br J Anaesth. 2010; 104: 490-495
12. Falcão LF, Perez MV, De Castro I, Yamashita AM, Tardelli MA, Amaral JL. Minimum effective volume of 0.5% bupivacaine with epinephrine in ultrasound-guided interscalene brachial plexus block. Br J Anaesth. 2013; 110: 450-455
13. Gautier P, Vandepitte C, Ramquet C, De Coopman M, Xu D, Hadzic A. The minimum effective anesthetic volume of 0.75% ropivacaine in ultrasound-guided interscalene brachial plexus block. Anesth Analg. 2011; 113: 951-955
14. McNaught A, Shastri U, Carmichael N, et al. Ultrasound reduces the minimum effective local anaesthetic volume compared with peripheral nerve stimulation for interscalene block. Br J Anaesth. 2011; 106: 124-130
15. Renes SH, van Geffen GJ, Rettig HC, Gielen MJ, Scheffer GJ. Minimum effective volume of local anesthetic for shoulder analgesia by ultrasound-guided block at root C7 with assessment of pulmonary function. Reg Anesth Pain Med. 2010; 35: 529-534
16. Gupta PK, Hopkins PM. Effect of concentration of local anaesthetic solution on the ED50 of bupivacaine for supraclavicular brachial plexus block. Br J Anaesth. 2013; 111: 293-296
17. Pavičić Šarić J, Vidjak V, Tomulić K, Zenko J. Effects of age on minimum effective volume of local anesthetic for ultrasound-guided supraclavicular brachial plexus block. Acta Anaesthesiol Scand. 2013; 57: 761-766
18. Duggan E, El Beheiry H, Perlas A, et al. Minimum effective volume of local anesthetic for ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2009; 34: 215-218
19. Flohr-Madsen S, Ytrebø LM, Kregnes S, Wilsgaard T, Klaastad ø. Minimum effective volume of ropivacaine 7.5 mg/mL for an ultrasound-guided infraclavicular brachial plexus block. Acta Anaesthesiol Scand. 2013; 57: 495-501
20. ODonnell BD, Iohom G. An estimation of the minimum effective anesthetic volume of 2% lidocaine in ultrasound-guided axillary brachial plexus block. Anesthesiology. 2009; 111: 25-29
21. PonrouchM, Bouic N, Bringuier S, et al. Estimation and pharmacodynamic consequences of the minimum effective anesthetic volumes for median and ulnar nerve blocks: a randomized, double-blind, controlled comparison between ultrasound and nerve stimulation guidance. Anesth Analg. 2010; 111: 1059-1064
22. Cappelleri G, Aldegheri G, Ruggieri F, Carnelli F, Fanelli A, Casati A. Effects of using the posterior and anterior approaches to the lumbar plexus on the minimum effective anesthetic concentration (MEAC) of mepivacaine required to block the femoral nerve: a prospective, randomized up-and-down study. Reg Anesth Pain Med. 2008; 33: 10-16
23. Casati A, Fanelli G, Magistris L, Beccaria P, Berti M, Torri G. Minimum local anesthetic volume blocking the femoral nerve in 50% of cases: a double-blinded comparison between 0.5% ropivacaine and 0.5% bupivacaine. Anesth Analg. 2001; 92: 205-208
24. Paqueron X, Narchi P, Mazoit JX, Singelyn F, Bénichou A, Macaire P. A randomized, observer-blinded determination of the median effective volume of local anesthetic required to anesthetize the sciatic nerve in the popliteal fossa for stimulating and nonstimulating perineural catheters. Reg Anesth Pain Med. 2009; 34: 290-295
25. Cappelleri G, Aldegheri G, Ruggieri F, et al. Minimum effective anesthetic concentration (MEAC) for sciatic nerve: subgluteus and popliteal approaches. Can J Anesth. 2007; 54: 283-289
26. Taboada M, Rodríguez J, Valiño C, et al. What is the minimum effective volume of local anesthetic required for sciatic nerve blockade?. A prospective, randomized comparison between a popliteal and a subgluteal approach. Anesth Analg. 2006; 102: 593-597
27. González AP, Bernucci F, Pham K, Correa JA, Finlayson RJ, Tran DQH. Minimum effective volume of lidocaine for double-injection ultrasound-guided axillary block. Reg Anesth Pain Med. 2013; 38: 16-20
28. TranDQH, Dugani S, Correa JA, Dyachenko A, Alsenosy N, Finlayson RJ. Minimum effective volume of lidocaine for ultrasound-guided supraclavicular block. Reg Anesth Pain Med. 2011; 36: 466-469
29. Tran DQH, Dugani S, Dyachenko A, Correa JA, Finlayson RJ. Minimum effective volume of lidocaine for ultrasound-guided infraclavicular block. Reg Anesth Pain Med. 2011; 36: 190-194
30. Taha AM, Abd-Elmaksoud AM. Lidocaine use in ultrasound-guided femoral nerve block: what is the minimum effective anaesthetic concentration (MEAC90)?. Br J Anaesth. 2013; 110: 1040-1044
31. Techasuk W, Bernucci F, Cupido T, et al. Minimum effective volume of combined lidocaine-bupivacaine for analgesic subparaneural popliteal sciatic nerve block. Reg Anesth Pain Med. 2014; 39: 108-111
32. Vandepitte C, Gautier P, Xu D, Salviz EA, Hadzic A. Effective volume of ropivacaine 0.75% through a catheter required for interscalene brachial plexus blockade. Anesthesiology. 2013; 118: 863-867
33. Kant A, Gupta PK, Zohar S, Chevret S, Hopkins PM. Application of the continual reassessment method to dose-finding studies in regional anesthesia: an estimate of the ED95 dose for 0.5% bupivacaine for ultrasound-guided supraclavicular block. Anesthesiology. 2013; 119: 29-35
34. Gupta PK, Chevret S, Zohar S, Hopkins PM. What is the ED95 of prilocaine for femoral nerve block using ultrasound?. Br J Anaesth. 2013; 110: 831-836
35. Meddings JB, Scott RB, Fick GH. Analysis and comparison of sigmoidal curves: application to dose-response data. Am J Physiol. 1989; 257: G982-G989
36. Walsh G, Schwarz-Bloom R. General principles of the quantitative aspects of drug action. In: Walsh G, Schwarz-Bloom R, eds. Levines Pharmacology. Drug Action and Reaction. 7th ed. London, UK: Taylor and Francis; 2005
37. Ross EM, Kenakin TP. Pharmacodynamics. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001
38. Laurence DR, Bennett PN, Brown MJ. General Pharmacology. In: Laurence DR, Bennett PN, Brown MJ, eds. Clinical Pharmacology. 8th ed. New York: Churchill Livingstone; 1997
39. Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a précis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007; 107: 144-152
40. Chin R, Lee B. Dosing and intervention. In: Chin R, Lee B, eds. Principles and Practice of Clinical Trial Medicine. 4th ed. London, UK: Academic Press; 2008
41. Johns RA. Local anesthetics inhibit endothelium-dependent vasodilation. Anesthesiology. 1989; 70: 805-811
42. Bouvet L, Da-Col X, Chassard D, et al. ED50 and ED95 of intrathecal levobupivacaine with opioids for caesarean delivery. Br J Anaesth. 2011; 106: 215-220
43. Sheskey MC, Rocco AG, Bizzarri-Schmid M, Francis DM, Edstrom H, Covino BG. A dose-response study of bupivacaine for spinal anesthesia. Anesth Analg. 1983; 62: 931-935
44. Prentice RL. A generalization of the probit and logit methods for dose response curves. Biometrics. 1976; 32: 761-768
45. Durham SD, Flournoy N, Rosenberger WF. A randomwalk rule for phase 1 clinical trials. Biometrics. 1997; 53: 745-760
46. Stylianou M, Proschan M, Flournoy N. Estimating the probability of toxicity at the target dose following an up-and-down design. Stat Med. 2003; 22: 535-543
47. Stylianou M, Flournoy N. Dose finding using the biased coin up-and-down design and isotonic regression. Biometrics. 2002; 58: 171-177
48. Garrett-Mayer E. The continual reassessment method for dose-finding studies: a tutorial. Clin Trials. 2006; 3: 57-71
49. O'Quigley JO, Pepe M, Fisher L. Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics. 1990; 46: 33-48
50. O'Quigley J, Shen LZ. Continual reassessment method: a likelihood approach. Biometrics. 1996; 52: 673-684
51. Heyd JM, Carlin BP. Adaptive design improvements in the continual reassessment method for phase I studies. Stat Med. 1999; 18: 1307-1321